Wide-complex tachycardia: Difference between revisions

No edit summary
Line 16: Line 16:
####Mag 1-2gm IV over 60-90s, then infuse 1-2gm/hr
####Mag 1-2gm IV over 60-90s, then infuse 1-2gm/hr
###Synchronized cardioversion (100 J)
###Synchronized cardioversion (100 J)
##Irregular
##Irregular (tx as presumed preexcited a-fib)
###Unsynchronized cardioversion (200J)
###Unsynchronized cardioversion (200J)



Revision as of 21:11, 10 May 2011

Background

  • Consider hyperkalemia & dig toxicity

Treatment

  1. Pulseless - Unsynchronized cardioversion 200J
  2. Unstable - shock (sync 100J -200J monophasic, or 50-100J biphasic)
  3. Stable
    1. Regular (tx as presumed V-tach)
      1. 1st Line
        1. Procainamide (20mg/min)
        2. Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
          1. Agent of choice in setting of AMI or LV dysfunction
      2. 2nd Line
        1. Lidocaine 1-1.5mg/kg IV q5min, repeat prn until up to 300mg/hr
      3. Torsades de Pointes
        1. Mag 1-2gm IV over 60-90s, then infuse 1-2gm/hr
      4. Synchronized cardioversion (100 J)
    2. Irregular (tx as presumed preexcited a-fib)
      1. Unsynchronized cardioversion (200J)

DDx Regular

  1. V-tach
  2. Tachycardia + BBB
  3. Tachycardia + rate related BBB
  4. Hyperkalemia, meds (e.g. procainamide, flecainide, TCAs, dig)
  5. Pacemaker
  6. Tachycardia + Accessory pathway
  7. See V Tach vs. SVT

DDX Irregular

  1. A-fib + BBB
  2. A-fib + rate related BBB
    1. QRS widest with shortest R-R
  3. V-tach
  4. A-fib + hyperkalemia or meds
  5. Accessory pathway
    1. The danger = A.fib + aberrant pathway (in WPW)
      1. Do not use adenosine, beta blockers, dilt, or dig
      2. Changing morphology of QRS = inc poss
      3. Consider procainamide or ibutilide
      4. Shock if becomes unstable

See also

ACLS (2010 Guidelines)

V Tach vs. SVT

Source

Rosen's